Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography.
about
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTA population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer's diseaseTherapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late-onset schizophrenia-like psychosis (VLOSLP).Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.Therapeutic occupation of dopamine D2 antipsychotic receptors in Alzheimer's disease.
P2860
Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Towards a therapeutic window o ...... positron emission tomography.
@en
Towards a therapeutic window o ...... positron emission tomography.
@nl
type
label
Towards a therapeutic window o ...... positron emission tomography.
@en
Towards a therapeutic window o ...... positron emission tomography.
@nl
prefLabel
Towards a therapeutic window o ...... positron emission tomography.
@en
Towards a therapeutic window o ...... positron emission tomography.
@nl
P2093
P2860
P356
P1476
Towards a therapeutic window o ...... e positron emission tomography
@en
P2093
Andrew Mogg
Bonnita Nwosu
Chloe Clark-Papasavas
Joel T Dunn
John Joemon
Marcel Cleij
Paul Marsden
Robert Kessler
Rosemary Gomes
Stuart Brownings
P2860
P304
P356
10.1002/GPS.4090
P407
P577
2014-02-28T00:00:00Z